Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2009-03-25 Regulatory Filings
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2009
Regulatory Filings Classification · 88% confidence The document is a short press release dated March 25, 2009, announcing a future regulatory action (filing an Investigational New Drug application (IND) with the FDA) regarding a clinical compound (valomaciclovir) for Multiple Sclerosis. It is not a full financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is an announcement concerning a specific business development, likely related to clinical trials or regulatory milestones. Since there is no specific category for 'Clinical Trial Update' or 'Regulatory Milestone Announcement', and it is a general announcement that doesn't fit the other specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is 'Regulatory Filings' (RNS), as it is a general regulatory/business update.
2009-03-25 English
Annual Report 2008
Annual Report Classification · 100% confidence The document is an annual report for Medivir AB for the year 2008. It contains a comprehensive review of the company's activities, including a 'Vd har ordet' (CEO's statement), project portfolio details, financial highlights, and a list of contents that includes 'Resultaträkningar' (Income statements), 'Balansräkningar' (Balance sheets), and 'Revisionsberättelse' (Audit report). It is a full-year comprehensive report, not an announcement or a summary. FY 2008
2009-03-24 Swedish
Annual Report 2008
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Medivir for the year 2008. It contains a CEO's statement, business highlights, project portfolio details, financial summaries, and corporate governance information. It is clearly the full annual report rather than an announcement or a summary, as it includes detailed sections like 'Report of the directors', 'Income statement', 'Balance sheet', and 'Accounting principles'. FY 2008
2009-03-24 English
AGM Information 2009
AGM Information Classification · 100% confidence The document is explicitly titled "Kallelse till årsstämma i Medivir AB (publ)" which translates to 'Notice of Annual General Meeting in Medivir AB (publ)'. It details the date, time, location, procedures for shareholder participation, and presents a detailed agenda (Förslag till dagordning) covering the election of the chairman, approval of financial statements, dividend disposition, board elections, and remuneration guidelines. This content is the core material for convening and conducting an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2009-03-19 Swedish
Earnings Release 2008
Earnings Release Classification · 99% confidence The document is extremely short (227 characters) and is titled 'Correction Financial Statement 2008'. It provides a specific, corrected data point (Earnings per share for Q4 2008) and directs the reader to the company website for more information. This structure strongly suggests it is a brief announcement regarding a financial statement correction, rather than the full financial statement itself (which would be classified as 10-K or IR). Since it is a specific financial correction announcement and not a general regulatory filing (RNS) or a report publication announcement (RPA) about a major report, it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous, short-form financial update, or potentially an 'Audit Report / Information' (AR) if the correction relates to the audit, but RNS is the safer fallback for short, specific regulatory corrections not covered elsewhere. Given the options, RNS is the most appropriate catch-all for a brief, specific correction notice. Q4 2008
2009-02-19 English
Earnings Release 2008
Earnings Release Classification · 99% confidence The document is extremely short (239 characters) and is titled 'Rättelse bokslutskommuniké 2008' (Correction to Year-End Report 2008). It provides a single corrected data point (Result per share) and directs the reader to the company website for more information. This structure—a brief announcement correcting or summarizing a main report and pointing to the full document—strongly suggests it is an announcement about a filing rather than the comprehensive filing itself. Since it is a correction/update related to financial results, and given its brevity, it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were the initial release, but as a correction, RNS is more appropriate as a general regulatory update, or potentially an RPA if it were announcing the publication of the corrected report. Given the content is a direct correction to a financial communication ('bokslutskommuniké'), and it's not a full report, RNS is the most suitable general regulatory category for this brief correction notice. Q4 2008
2009-02-19 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.